Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Roentgenograms and gallium-67 scans and gallium-67 counts of
BAL
fluid samples, together with differential cell counts, have proved to be useful in assessing activity and lung involvement in sarcoidosis. In active pulmonary sarcoidosis gallium-67 scans are usually positive. Quantitation of gallium-67 uptake in lung scans, however, may be difficult. Because gallium-67 uptake and cell counts in
BAL
fluid may be correlated, we set out to investigate gallium-67 activity in
BAL
fluid recovered from patient of different groups. Sixteen patients with recently diagnosed and untreated sarcoidosis, nine patients with healthy lungs, and five patients with
CFA
were studied. Gallium-67 uptake of the lung, gallium-67 activity in the lavage fluid, SACE and LACE levels, and alpha 1-AT activity were measured. Significantly more gallium-67 activity was found in
BAL
fluid from sarcoidosis patients than in that from
CFA
patients (alpha = .001) or patients with healthy lungs (alpha = .001). Gallium-67 activity in
BAL
fluid could be well correlated with the number of lymphocytes in
BAL
fluid, but poorly with the number of macrophages. Subjects with increased levels of SACE or serum alpha 1-AT showed higher lavage gallium-67 activity than did normals, but no correlation could be established. High gallium-67 activity in lavage fluid may be correlated with acute sarcoidosis or physiological deterioration; low activity denotes change for the better. The results show that gallium-67 counts in
BAL
fluid reflects the intensity of gallium-67 uptake and thus of activity of pulmonary sarcoidosis.
...
PMID:Gallium-67 activity in bronchoalveolar lavage fluid in sarcoidosis. 301 57
Fibrosing alveolitis may occur alone (
CFA
) or in association with systemic sclerosis (FASSc). FASSc was recently shown to have a prognostic advantage over
CFA
. Because interleukin-8 (IL-8) is likely to be a major determinant of neutrophil alveolitis, we evaluated IL-8 expression in patients with
CFA
and FASSc and compared it with that in normal individuals and sarcoidosis and systemic sclerosis patients without pulmonary involvement (SSc no FA). IL-8 protein in bronchoalveolar lavage fluid (BALF) was assessed by immunoassay, and IL-8 mRNA expression was assessed using Northern analysis and reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization of lung parenchyma. Compared with normal subjects, IL-8 concentration was significantly greater in both
CFA
(p < 0.001) and FASSc groups (p < 0.05) but no different in sarcoidosis. The IL-8 concentration in
CFA
was higher than in FASSc (p < 0.01) and was related to
BAL
% neutrophils (rs = 0.48, p < 0.01). IL-8 mRNA expression evaluated by Northern analysis was seen only in patients with
CFA
and FASSc and was related to
BAL
% neutrophils (rs = 0.63, p < 0.01). We suggest that IL-8 is a key factor in the pathogenesis of fibrosing alveolitis and that the poorer prognosis of
CFA
compared with FASSc is related to higher levels of IL-8 within the lower respiratory tract.
...
PMID:Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. 773 20